ArticleJournal of hepatocellular carcinoma2022

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.